# ARA-290 for sarcoidosis small fiber neuropathy: pilot trial

Source: https://pepvault.app/research/ara-290-heij-2012

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [ARA-290](https://pepvault.app/research#ara-290)

Randomized trial · people

# ARA-290 improved small fiber neuropathy symptoms in sarcoidosis

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This early, small human trial found ARA-290 well tolerated in sarcoidosis, with better neuropathy symptom scores than placebo but no edge on pain ratings.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 22
- **Published:** 2012
- **Journal:** Mol Med

## What they tested

The team tested whether ARA-290 is safe and eases symptoms of small fiber neuropathy (damage to the body's thinnest nerve fibers, often causing pain) in people with sarcoidosis.

## How the study was done

A randomized, double-blind, placebo-controlled pilot trial in 22 patients with sarcoidosis, neuropathy and a pain score of at least 5. The trial gave 2 mg of ARA-290 (12 patients) or a placebo, a dummy treatment (10 patients), into a vein three times a week for 4 weeks.

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Clinical exams and lab tests turned up no safety problems. At week 4, scores on the small fiber neuropathy screening list (SFNSL, a symptom questionnaire) fell by 11.5 points in the ARA-290 group, compared with 2.9 points on placebo, a significant difference (p < 0.05). The ARA-290 group also showed significant shifts from its own starting point in the pain and physical functioning parts of the SF-36, a quality-of-life survey (changes of -23.4 and -14.6). Pain intensity and fatigue scores got better by the same amount in both groups, and depression scores did not move.

## What it doesn’t show

This was a small, 4-week pilot trial, and the quality-of-life changes were measured against each patient's starting point rather than against placebo. Pain and fatigue improved no more with ARA-290 than with placebo.

## The paper

Heij et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med. 2012.

- [PubMed (PMID 23168581)](https://pubmed.ncbi.nlm.nih.gov/23168581/)
- [The paper (DOI 10.2119/molmed.2012.00332)](https://doi.org/10.2119/molmed.2012.00332)

## The compound

- [ARA-290: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on ARA-290

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017) Randomized trial · people · 2017
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013) Randomized trial · people · 2013
- [ARA-290 eased nerve-injury pain for up to 20 weeks in rats](https://pepvault.app/research/ara-290-swartjes-2014) Animal study · rats · 2014
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

## The library

- [ARA-290](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
